Fonte: Clinical Hypertension. Unidades: FM, EE
Assuntos: HIPERTENSÃO, COVID-19, FARMACOTERAPIA, ADESÃO À MEDICAÇÃO
ABNT
GUIMARÃES, Mayra Cristina da Luz Pádua et al. Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study. Clinical Hypertension, v. 28, n. 35, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1186/s40885-022-00219-0. Acesso em: 22 ago. 2024.APA
Guimarães, M. C. da L. P., Coelho, J. C., Santos, J. dos, Higa, C. B. de O., Flórido, C. F., Lee, R. J. W., et al. (2022). Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study. Clinical Hypertension, 28( 35), 1-10. doi:10.1186/s40885-022-00219-0NLM
Guimarães MC da LP, Coelho JC, Santos J dos, Higa CB de O, Flórido CF, Lee RJW, Paes GS, Silva GV da, Drager LF, Pierin AMG. Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study [Internet]. Clinical Hypertension. 2022 ; 28( 35): 1-10.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1186/s40885-022-00219-0Vancouver
Guimarães MC da LP, Coelho JC, Santos J dos, Higa CB de O, Flórido CF, Lee RJW, Paes GS, Silva GV da, Drager LF, Pierin AMG. Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study [Internet]. Clinical Hypertension. 2022 ; 28( 35): 1-10.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1186/s40885-022-00219-0